OPKO Health
OPK
#6204
Rank
HK$8.62 B
Marketcap
HK$11.56
Share price
-1.67%
Change (1 day)
4.47%
Change (1 year)

OPKO Health (OPK) - P/B ratio

P/B ratio as of August 2026 : 0.9139

According to OPKO Health 's latest financial reports the company has a price-to-book ratio of 1.89433.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

OPKO Health - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-310.79519.03%
2024-12-310.7292-13.21%
2023-12-310.840335.86%
2022-12-310.6185-68.2%
2021-12-311.9422.84%
2020-12-311.58159.64%
2019-12-310.6098-38.11%
2018-12-310.9852-33.73%
2017-12-311.49-40.02%
2016-12-312.48-10.41%
2015-12-312.77-46.44%
2014-12-315.1729.52%
2013-12-313.99-44.83%
2012-12-317.23-5.82%
2011-12-317.68-81.12%
2010-12-3140.7176.69%
2009-12-3114.7-98.36%
2008-12-318972861.26%
2007-12-3130.3-95.6%
2006-12-3168886593.57%
2005-12-310.793341.35%
2004-12-310.5612-59.04%
2003-12-311.37288.78%
2002-12-310.3524

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.87 761.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.69 304.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
2.59 183.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
6.73 636.68%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
3.11 240.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
29.3 3,103.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
5.16 464.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
6.62 624.27%๐Ÿ‡บ๐Ÿ‡ธ USA